NasdaqGM - Delayed Quote USD

Concert Pharmaceuticals, Inc. (CNCE)

8.37 0.00 (0.00%)
As of April 4 at 4:00 PM EDT. Market Open.

Key Executives

Concert Pharmaceuticals, Inc.

Description

Corporate Governance

Concert Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Mar 16, 2023
    15-12G: Notice of termination of registration of a class of securities under Section 12(g)
    See Full Filing
  • Mar 06, 2023
    S-8 POS: Offering Registrations
    See Full Filing
  • Feb 14, 2023
    SC 13G/A: Tender Offer/Acquisition Reports
    See Full Filing
  • Feb 10, 2023
    SC 13G: Tender Offer/Acquisition Reports
    See Full Filing
  • Feb 02, 2023
    SC 14D9: Tender Offer/Acquisition Reports
    See Full Filing

Upcoming Events

Related Tickers

DICE
 
CALA Calithera Biosciences, Inc.
0.0301
+19.96%
 
CMPX Compass Therapeutics, Inc.
1.5200
+2.01%
 
DAWN Day One Biopharmaceuticals, Inc.
16.65
+8.27%
 
ANNX Annexon, Inc.
4.5950
+1.10%
 
RVMD Revolution Medicines, Inc.
36.66
+0.63%
 
CORT Corcept Therapeutics Incorporated
23.61
+5.85%
 
AVRO AVROBIO, Inc.
1.2100
+0.83%
 
MIRM Mirum Pharmaceuticals, Inc.
24.78
+2.52%
 
CLDX Celldex Therapeutics, Inc.
38.65
-0.51%